Floatz logo

IMMUNOGLOBULIN G1, ANTI-(HUMAN PROGRAMMED DEATH-LIGAND 1) (HUMAN MONOCLONAL ZKAB001 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL ZKAB001 .LAMBDA.-CHAIN, DIMER

Local Progression or Metastatic Melanoma With Failed First-line Treatment

Lee's Pharmaceutical Limitedmonoclonal_antibodyPhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

103 Active assets in the Local Progression or Metastatic Melanoma With Failed First-line Treatment cohort.

Asset / SponsorPhaseRating
Cediranib
M.D. Anderson Cancer Center
Phase 2BBB
DACARBAZINE
Shanghai Junshi Bioscience Co., Ltd.
Phase 4BBB
Ifa
Craig L Slingluff, Jr
Phase 2BB
Nivolumab
Bristol-Myers Squibb
Phase 4BB
Therapeutic Autologous Lymphocytes
Fred Hutchinson Cancer Center
Phase 2BB

View all 50 →

Same molecule, other indications

IMMUNOGLOBULIN G1, ANTI-(HUMAN PROGRAMMED DEATH-LIGAND 1) (HUMAN MONOCLONAL ZKAB001 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL ZKAB001 .LAMBDA.-CHAIN, DIMER is also rated in:

Extensive Stage Small Cell Lung CancerDormant
BB
Indicative ·
67 / 100
View asset →
small cell lung carcinomaDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →